Tag: genomics
-
New Company Acquires Off-the-Shelf T-Cell Cancer Therapies
A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells.
-
Cough Suppressant Produced from Engineered Yeast Cells
A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast.
-
Antibodies Licensed for Multi-Target Immunotherapies
MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets.
-
RNA Treatment Tested for West Nile Virus
A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage.
-
Crowdsourced Project Building Whole Beta Cell Model
A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas.
-
Crispr Enhanced to Find, Edit Tiny Mutations
A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs.
-
High False-Positive Rate Found in Consumer Genetic Tests
Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous.
-
Genome Editing Yields Quality Beer Without Hops
Academic scientists studying synthetic biology with help from professional brewers used genome editing to engineer yeast that produces beer with the taste of hops, but without adding hops.
-
Crispr Techniques Devised for Editing RNA
Geneticists and bioengineers developed a technology for applying genomic editing techniques known as Crispr to ribonucleic acid, or RNA, transcribed from the genetic code in a person’s DNA.
-
FDA Clears Consumer Genetic Breast Cancer Risk Tests
The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer.